Compile Data Set for Download or QSAR
maximum 50k data
Found 677 Enz. Inhib. hit(s) with all data for entry = 592
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280555(US10030020, Example 100 | US10781211, Example 100)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280556(US10030020, Example 101 | US10781211, Example 101)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280557(US10030020, Example 102 | US10781211, Example 102)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280559(US10030020, Example 104 | US10781211, Example 104)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280560(US10030020, Example 105 | US10781211, Example 105)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280562(US10030020, Example 107 | US10781211, Example 107)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280563(US10030020, Example 108 | US10781211, Example 108)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280564(US10030020, Example 109 | US10781211, Example 109)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280565(US10030020, Example 110 | US10781211, Example 110)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280566(US10030020, Example 111 | US10781211, Example 111)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280567(US10030020, Example 112 | US10781211, Example 112)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280568(US10030020, Example 113 | US10781211, Example 113)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280569(US10030020, Example 114 | US10781211, Example 114)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280571(US10030020, Example 116 | US10781211, Example 116)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280574(BDBM280666 | US10030020, Example 119 | US10781211,...)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM280574(BDBM280666 | US10030020, Example 119 | US10781211,...)
Affinity DataIC50: <100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280575(US10030020, Example 120 | US10781211, Example 120)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM280575(US10030020, Example 120 | US10781211, Example 120)
Affinity DataIC50: <100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280576(US10030020, Example 121 | US10781211, Example 121)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM280576(US10030020, Example 121 | US10781211, Example 121)
Affinity DataIC50: <100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280577(US10030020, Example 122 | US10781211, Example 122)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM280577(US10030020, Example 122 | US10781211, Example 122)
Affinity DataIC50: <100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280578(US10030020, Example 123 | US10781211, Example 123)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM280578(US10030020, Example 123 | US10781211, Example 123)
Affinity DataIC50: <100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280579(US10030020, Example 124 | US10781211, Example 124)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280580(US10030020, Example 125 | US10781211, Example 125)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280581(US10030020, Example 126 | US10781211, Example 126)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280583(US10030020, Example 128 | US10781211, Example 128)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280584(US10030020, Example 129 | US10781211, Example 129)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280585(US10030020, Example 130 | US10781211, Example 130)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280586(US10030020, Example 131 | US10781211, Example 131)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280587(US10030020, Example 132 | US10781211, Example 132)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280588(US10030020, Example 133 | US10781211, Example 133)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM280588(US10030020, Example 133 | US10781211, Example 133)
Affinity DataIC50: <100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280589(US10030020, Example 134 | US10781211, Example 134)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Homo sapiens (Human))
Abide Therapeutics

US Patent
LigandPNGBDBM280589(US10030020, Example 134 | US10781211, Example 134)
Affinity DataIC50: <100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280590(US10030020, Example 135 | US10781211, Example 135)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoacylglycerol lipase ABHD2(Mus musculus (Mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280592(US10030020, Example 137 | US10781211, Example 137)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoacylglycerol lipase ABHD2(Mus musculus (Mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280593(US10030020, Example 138 | US10781211, Example 138)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280595(US10030020, Example 140 | US10781211, Example 140)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280480(US10030020, Example 25 | US10781211, Example 25)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280481(US10030020, Example 26 | US10781211, Example 26)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280483(US10030020, Example 28 | US10781211, Example 28)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280484(US10030020, Example 29 | US10781211, Example 29)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280485(US10030020, Example 30 | US10781211, Example 30)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280486(US10030020, Example 31 | US10781211, Example 31)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280487(US10030020, Example 32 | US10781211, Example 32)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280488(US10030020, Example 33 | US10781211, Example 33)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280489(US10030020, Example 34 | US10781211, Example 34)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMonoglyceride lipase(Mus musculus (mouse))
Abide Therapeutics

US Patent
LigandPNGBDBM280490(US10030020, Example 35 | US10781211, Example 204)
Affinity DataIC50: <100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 677 total ) | Next | Last >>
Jump to: